Critical Care & Emergencies (all articles)
Review: clinical presentation and management of COVID ‐19
20 Jul, 2020 | 07:51h | UTCClinical presentation and management of COVID ‐19 – Medical Journal of Australia
The Zentensivist manifesto. Defining the art of critical care
20 Jul, 2020 | 07:42h | UTCThe Zentensivist Manifesto. Defining the Art of Critical Care – ATS Scholar
Source: Grupo UTIclínica – HCFMUSP
[Abstract Only] Randomized trial: urgent endoscopic retrograde cholangiopancreatography with sphincterotomy vs. conservative treatment in predicted severe acute gallstone pancreatitis
20 Jul, 2020 | 07:44h | UTC
Related Commentary on Twitter
Routine or on-demand ERCP in pred severe biliary #pancreatitis? APEC trial today @TheLancet: major complications 38%/117 pts urgent ERCP incl sphincterotomy vs 44%/113 pts with ERCP on-demand. ERCP can be reserved for cholangitis/ persistent cholestasis. https://t.co/kz1jfTQIf8 pic.twitter.com/ZfkARKwvGv
— Marc Besselink (@MarcBesselink) July 17, 2020
Palliative care for patients with severe Covid-19
17 Jul, 2020 | 08:51h | UTCPalliative care for patients with severe covid-19 – The BMJ
RIP Hydroxychloroquine? 2 studies show no benefit in early/mild COVID-19
17 Jul, 2020 | 08:59h | UTCCommentaries: New Covid-19 study, despite flaws, adds to case against hydroxychloroquine – STAT AND Hydroxychloroquine also doesn’t help Covid-19 patients who aren’t hospitalized, new study finds – CNN
Review: Perioperative management of oral glucose-lowering drugs in the patient with Type 2 Diabetes
17 Jul, 2020 | 08:24h | UTC
[Preprint] RECOVERY trial: effect of hydroxychloroquine in hospitalized patients with COVID-19
16 Jul, 2020 | 08:39h | UTC
Related Commentary on Twitter (Thread – Click for more)
HYDROXYCHLOROQUINE – Recovery trial results finally out – and hopefully puts nail in coffin. Out of 4700 people randomized… HCQ did NOT lower #covid19 mortality. It anything it was trending in wrong direction. Thread ? https://t.co/6Iu0NEejON pic.twitter.com/6l85Nmz4id
— Eric Feigl-Ding (@DrEricDing) July 15, 2020
Covid-19: experts criticize claim that remdesivir cuts death rates
16 Jul, 2020 | 08:31h | UTCCovid-19: Experts criticise claim that remdesivir cuts death rates – The BMJ
Related Commentary on Twitter
Experts have criticised pharmaceutical firm Gilead Sciences after it released data suggesting that its antiviral drug remdesivir can reduce death rates for patients with covid-19. They say the research is intrinsically flawed @MartinLandray https://t.co/a1q2FxMa7C
— The BMJ (@bmj_latest) July 14, 2020
Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19
16 Jul, 2020 | 08:24h | UTCCommentary: Coagulation disorder in COVID-19 – The Lancet Haematology
Related Commentary on Twitter
NEW research—Results of a retrospective study including 380 patients with #COVID19 admitted to Wuhan Union Hospital explores haematological characteristics and related risk factors https://t.co/lbDVw5lFBC pic.twitter.com/0qlvHzfzhR
— The Lancet Haematology (@TheLancetHaem) July 11, 2020
[Abstract Only] Randomized trial: ticagrelor and aspirin vs. aspirin alone in acute ischemic stroke or TIA
16 Jul, 2020 | 08:17h | UTCCommentaries: Acute Stroke or Transient Ischaemic Attack Treated With Ticagrelor and ASA for Prevention of Stroke and Death – THALES – American College of Cardiology AND Ticagrelor and aspirin taken post stroke may decrease the risk of recurrent stroke – 2 Minute Medicine
[Abstract Only] Randomized trial: timing of initiation of renal-replacement therapy in acute kidney injury
16 Jul, 2020 | 08:18h | UTC
ACC Consensus on management of anticoagulant-related bleeding
15 Jul, 2020 | 08:12h | UTCKey Points: ACC Consensus on Management of Anticoagulant-Related Bleeding
Researchers develop COVID-19 mortality risk calculator
14 Jul, 2020 | 08:33h | UTCResearchers develop COVID-19 mortality risk calculator – News Medical
Original Study [Preprint]: COVID-19 Mortality Risk Assessment: An International Multi-Center Study – medRxiv
See Calculator: COVID Analytics
Related Commentary on Twitter
Our team developed and validated a new COVID-19 mortality risk score using data from 33 hospitals across four different countries. I am very proud of this international collaboration. The paper is now available on medrxiv: https://t.co/VGEPJYqbEf
— Agni Orfanoudaki (@AgniOrfanoudaki) July 10, 2020
Guideline executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections
14 Jul, 2020 | 08:11h | UTC
Review: Pathophysiology, Transmission, Diagnosis, and Treatment of COVID-19
13 Jul, 2020 | 00:29h | UTC
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
What do we know about convalescent plasma as a possible treatment for #COVID19? https://t.co/VZgPyW5HJy The @CochraneHaem living systematic review has now been updated, but uncertainty remains about the possible benefits & harms of #plasma. @CochraneUK's @SarahChapman30 explains. pic.twitter.com/9RQi6sDFV9
— Cochrane UK (@CochraneUK) July 10, 2020
Case Reports: 2 Adults with Kawasaki-like Multisystem Inflammatory Syndrome Associated with COVID-19
13 Jul, 2020 | 00:05h | UTCCase Report 1: An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 – The Lancet
Case Report 2: An adult presentation consistent with PIMS-TS – The Lancet Rheumatology
Related Commentary on Twitter
First reports of Kawasaki-like #SARSCoV2 multi-system inflammatory syndrome in adultshttps://t.co/FYNWlxdk9q @TheLancet https://t.co/lnHMUxA7Ux @TheLancetRheum
21 yo in London, 45 yo in New York City pic.twitter.com/lLmSRzBjs4— Eric Topol (@EricTopol) July 11, 2020
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke
13 Jul, 2020 | 00:03h | UTC
[Abstract Only] Randomized Trial: Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria
12 Jul, 2020 | 23:57h | UTCIntravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial – Annals of Emergency Medicine (link to abstract – $ for full-text)
Cardiac Troponin for the Diagnosis and Risk-Stratification of Myocardial Injury in COVID-19
10 Jul, 2020 | 09:34h | UTC
Related Commentary on Twitter
Troponin increases, due to chronic myocardial injury, acute nonischemic myocardial injury or type 1 or 2 MI, are common in #COVID19 and associated with adverse outcomes. Learn more in this #JACC Review Topic of the Week: https://t.co/oOBjCCx8KJ @yadersandoval @JJheart_doc pic.twitter.com/r9HPCJ4Knd
— JACC Journals (@JACCJournals) July 8, 2020
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
10 Jul, 2020 | 09:30h | UTCIncidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic – JAMA Network Open
Commentary: Researchers find rise in broken heart syndrome during COVID-19 pandemic – Cleveland Clinic
Podcast: Acute Lung Injury in Covid-19
9 Jul, 2020 | 09:28h | UTCAudio Interview: Acute Lung Injury in Covid-19 – New England Journal of Medicine
COVID-19-associated Acute Respiratory Distress Syndrome: Is A Different Approach to Management Warranted?
8 Jul, 2020 | 01:02h | UTC
Meta-Analysis: Standardized Management for Hypoxemic Respiratory Failure and ARDS
8 Jul, 2020 | 01:01h | UTC